https://ras-signal.com/your-ne....urophysiological-str
Thus, we hypothesized that pretreatment with gemcitabine would further improve the sensitivity of PDAC to nab-paclitaxel by increasing Cav-1 appearance and nab-paclitaxel uptake. We investigated the susceptibility of various gemcitabine and nab-paclitaxel treatment regimens in a panel of PDAC cell lines and orthotopic xenograft models. The sensitiveness of various treatment regimens was weighed against the conventional concurrent therapy. Pretreatment with gemcitabin
Like
Comment
Share
